Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

Lilly backs Bluetooth insulin device and app firm

Invests in San Diego-based medical device company Companion Medical

Digital pharmaLilly has invested in a company that's developing a Bluetooth-enabled insulin pen and associated smartphone app.

The firm will also sit on the board of San Diego-based medical device firm Companion Medical, which is developing advanced systems for delivery of insulin and other drugs.

Divakar Ramakrishnan, vice president for delivery and device research and development at Lilly, said: “Lilly is focused on delivering the broadest portfolio of diabetes treatments in the industry, including innovative delivery methods to advance the treatment of diabetes.

“Companion's smart pen and app represent innovation that could one day fill a gap for millions of people with diabetes.” 

Companion Medical said Lilly's investment, along with that from other investors, could potentially enable it to complete testing of its technology and submit it to the FDA for approval. 

For Lilly it continues its application of digital technologies, many of which have been made under its diabetes alliance with Boehringer Ingelheim.

These include a diabetes management game and an online behavioural change programme.

28th May 2015

From: Healthcare

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
HAVAS Just::

HAVAS Just:: is a different kind of healthcare communications agency. Our mission is to create campaigns that make people think....

Latest intelligence

The ALS patient journey
Nick Goldup is the Director of Care Improvement at the Motor Neuron Disease Association (MNDA). Here, he offers his insights into the journey for patients with ALS and explores the...
Equipping your medical affairs teams with solutions to navigate the healthcare landscape
Dr Tyler Ray, OPEN Health Medical Communications...
Protein degraders
Can protein degraders unlock ‘undruggable’ drug targets?
Exploring a new and exciting area of small-molecule drug discovery...

Infographics